SanegeneBio annonce une collaboration mondiale de licence sur l'ARNi avec Genentech

At Genentech, we push the boundaries of science, always striving for breakthroughs that could change the future for people living with cancer. With breast cancer affecting millions of people, the need for new medicines inspires our team to give their best every day. Hear their stories on what working in breast cancer means to them. #BreastCancerAwarenessMonth | Genentech

Genentech | LinkedIn

In breast cancer, over 40% of HR cases have PIK3CA mutations, driving overactive PI3K signaling that fuel cancer growth. Marie-Gabrielle Braun, Senior Principal Scientist & Project Leader at Genentech, uses everyday objects to explain how cancer therapies are becoming more precise in going after mutated pathways, enabling new ways to fight back while sparing healthy cells. | Genentech

Many personalized cancer treatments aim to block out-of-control signals that fuel tumor growth. Targeting the PI3K pathway, which drives the growth of many cancers including #breastcancer, has been a challenging goal for researchers. Anwesha Dey, Senior Director & Scientist in Discovery Oncology at Genentech, uses everyday objects to explain how discoveries are enabling a new scientific advancement which not only blocks mutated signals, but also destroys the mutated proteins. | Genentech

After finding out she had breast cancer, Bobbi found strength in talking with other women who had similar diagnoses. She shares why it's important to find and connect with other people who have shared experiences. | Genentech

Graduates

Process Engineer III

Careers | RailWorks